Sign In
Buy RAIN
$2.21
-0.115 (-4.96%)
At Close: Jun 03, 2026
Rain Therapeutics to Report Second Quarter 2021 Financial Results and Highlights of Recent Progress on August 10, 2021
08:00am, Tuesday, 03'rd Aug 2021
NEWARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Rain Therapeutics Inc., (NasdaqGS: RAIN) a late-stage company developing precision oncology therapeutics, today announced it will report financial res
RAIN Stock Price: 9.39% Increase Explanation
07:47am, Wednesday, 26'th May 2021
The stock price of Rain Therapeutics Inc (NASDAQ: RAIN) increased by 9.39% yesterday. This is why it happened.
Rain Therapeutics Appoints Robert Doebele, M.D., Ph.D. as President
08:00am, Thursday, 20'th May 2021
Dr. Doebele, Rain co-founder, will continue to serve as chief scientific officer Dr. Doebele, Rain co-founder, will continue to serve as chief scientific officer
Rain Therapeutics Announces Pricing of Initial Public Offering
07:03pm, Thursday, 22'nd Apr 2021
NEWARK, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- Rain Therapeutics Inc. (“Rain”), a clinical-stage company developing precision oncology therapeutics, today announced the pricing of its initial
